Abstract
We previously proposed that women with menopausal vasomotor symptoms (VMS) may 2 differ from those without with respect to cardiovascular risk factors [1] . In a large 3 community-based sample of perimenopausal women, we indeed found that women with 4 symptoms of flushing or night sweats have increased BMI, cholesterol levels, systolic and 5 diastolic blood pressures compared to women without VMS [2] . Recent findings showing that However, the exact mechanism of how estrogen levels are related to VMS is still unknown.
12
Furthermore, the estrogen deficit accompanying menopause is also thought to play a 13 dominant role in the increased cardiovascular disease (CVD) risk after menopause [6] .
14 Therefore, the relationship between VMS and CVD risk factors may reflect the effect of 15 decreasing estradiol levels.
16
The present study was set up to extend our findings in another population-based 17 sample of perimenopausal women in whom also other markers of CVD risk were measured,
18
such as lipoprotein sub fractions and glucose. Furthermore, we aimed at examining the 19 association between circulating estradiol levels and VMS, and whether a possible association 20 between VMS and cardiovascular risk factors can be explained by estradiol levels. 
Vasomotor symptoms

12
To assess the presence of VMS, two questions were asked. The first question was "Do you depression. Both questions were to be answered with yes or no.
19
The questionnaire was a composite of several pre-existing and validated 20 questionnaires [9] and some questions were validated in a subset prior to general mailing. 
Glucose
18
We did not find an association for symptoms of flushing/sweats and glucose level. Symptoms 
23
All results were essentially similar in the subgroup of women with a natural 24 menopause, and in the subgroup of women not using OCs or HT (data not shown). explained by the women's circulating estradiol levels.
8
To appreciate the findings, some aspects of the present study need to be addressed.
9
A possible limitation includes the cross-sectional design of the study. However, we expect 10 that effects of VMS on several risk factors, such as blood pressure, are more acute effects, and 11 therefore this has probably not influenced our results to a large extent. In the present study we 12 found some small changes to be statistically significant. However, even small changes in risk Therefore, the higher systolic blood pressure of 2 mm/Hg and the higher total cholesterol of 17 0.14 mmol/L among the symptomatic women in our study might be related to about 4% and an explanation for our finding that symptoms of sweats only had a stronger effect on 8 cardiovascular risk factors than symptoms of flushing/sweats combined.
In our analyses, we additionally adjusted for estradiol level, which was measured only 14 Obviously, it is a point of discussion whether or not it is necessary to adjust for BMI in 15 the analyses regarding blood pressure and lipids. In our view, BMI is an essential determinant 16 of blood pressure [12] , and also causally related to endocrine and metabolic changes with 17 menopause and factors in the causal pathway should not be included in the regression models.
18
The fact that adding BMI to the models weakened the results supports the view that BMI lies 19 in the causal pathway and that adjustment has led to an overcorrection.
20
The focus of studies unraveling the etiology of VMS has mainly been on hot flushes and 21 not that much on symptoms of sweating. However, we assume the mechanism of sweating is Table 1 Characteristics of the study population of 5,857 women according to presence 
